Category: Africa

Expands COVID-19 Research Toolkit with novel hACE2 AC22 Mouse

RENSSELAER, N.Y., April 29, 2021 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit.

In October 2020, Taconic launched its first hACE2 model. The AC70 mouse experiences a lethal response to infection by SARS-CoV-2, the virus that causes COVID-19. Conversely, the new AC22 mouse is lethality-resistant, enabling therapeutic, vaccine, and post-infection symptom research.

Although various hACE2 mouse models of lethal SARS-CoV-2 infection exist, the hACE2 AC22 lethality-resistant model is important because it permits study of sublethal infection. Most humans infected with SARS-CoV-2 survive, and an animal model which replicates sublethal disease and recovery is needed. The hACE2 AC22 mouse provides a longer study window to assess drug efficacy compared to lethal infection models.

“While vaccines bring hope of an end to the pandemic, research on COVID-19 is still needed,” shared Dr. Michael Seiler, vice president of commercial models at Taconic. “There is a huge population of people who have now had the disease. We need models that also survive this disease long enough to aid in replicating that human condition. It cannot be overstated just how important this new AC22 model is in enabling that research.”

Study ready cohorts of animals are available for immediate ordering.

To learn more about hACE2 mice or Taconic’s Coronavirus Toolkit, please contact Taconic at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email info@taconic.com.

About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia, and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact: Kelly Owen Grover
Director of Marketing Communications
(518) 697-3824
kelly.grover@taconic.com

GSB Group doubts in gold reserves of Karatbars and the V999 Coin as well as the existence of the Osint Group

HAMBURG, Germany, April 28, 2021 (GLOBE NEWSWIRE) — The following is a GSB statement, on the non-existent Osint Group and the doubts about Karatbars’ existing gold and the V999 fraud in connection with Rainer von Holst.

If fraud and abuse of title (also called imposture) knows no bounds due to a lack of awareness of injustice, then one can call oneself a US lawyer and US notary public in hiding and living illegally in the United States of America (USA), as Rainer von Holst alias Jan Faber or Dr. Peter Klein, among others, demonstrably did recently in an e-mail to a news agency in the Federal Republic of Germany.

It is a fact that the allegedly gold-backed V999 Coin cannot have an “auditor” with the name “Osint Group”, as Harald Seiz and E-Karat International claim in their white paper (https://v999.gold//documents/v999-platform-white-paper.pdf) and to various investors, since this company does not even exist, but the Osint Group has merely sprung from the questionable imagination of Rainer von Holst, who put an “Osint Group” logo and a https://osint.group construction kit website on the internet for this purpose.

In this context, the affiliates who deal with the allegedly gold-backed V999 Coin and actively advertise for it have to face the question of complicity, here in relation to the responsibility towards the gold investors, with regard to demonstrably ongoing investigations by the public prosecutor’s office against Rainer von Holst and his network.

That the Karatbars boss Harald Seiz has lured his investors directly to the V999 platform of the allegedly gold-backed V999 Coin with the BUV, UNV and QR gold codes, whereby the non-existence of gold auditors (Osint Group) has been proven, are facts. The reality is also that Karatbars investor gold accounts have been linked to those of the V999 Coin, as can be seen on YouTube and various affiliates advertise how to link Karatbars accounts to the V999 platform with just one click.
Source: https://www.youtube.com/watch?app=desktop&v=iYOK1L2CSj0

Moreover, investors have been waiting for 2 (two) years for the gold invested as well as purchased and already saved by investors, which is why there are countless complaints to authorities from investors who call it an international fraud, as one hears more and more often.

Already the renowned German business newspaper “Handelsblatt” reported in June 2020, under the title: “The public prosecutor doubts the gold reserves of the Karatbars Group”, about the massive doubts regarding the possible non-existent gold.
Source: https://www.handelsblatt.com/finanzen/maerkte/devisen-rohstoffe/dubioser-goldhaendler-die-staatsanwaltschaft-zweifelt-an-den-goldreserven-der-karatbars-gruppe/25945106.html

In this round dance, Jakob B. appears, who returns in the chat of https://t.me/karatbarslawsuit, whereby von Holst has been claiming for some time that he has bought journalists, which is currently the subject of investigations by the public prosecutor’s office.

Chris Saunders is described by Rainer von Holst as a “criminal” and a “stupid talker”, whom Jakob B. is currently suing, according to a statement made by Rainer von Holst to media representatives. This is surprising, because it was Chris Saunders in the USA who recently stated in a video that he had an engagement (assignment) from Jakob B. and a renowned German business newspaper.
Source: https://facebook.com/24karatchris/videos/177054424240274

As Rainer von Holst’s scam has been known for a long time, the internationally renowned Stiftung Warentest already reported on the impostor and blackmailer in 2018.
Source: https://www.test.de/Rainer-von-Holst-Warum-wird-Anlagehai-nicht-ausgeliefert-5594662-0

In his obvious delusions of grandeur as a fraudster, blackmailer and impostor, Rainer von Holst forgot that in this day and age it does not take very long to find out whether a person is really a notary and lawyer, for which it is moreover absolutely necessary that the person has US citizenship, as the US Embassy in London has informed us factually – which exposes the baseless lies of Rainer von Holst and his network.

Here every person can check that Rainer von Holst, contrary to his insane claims, is not a notary and also not a lawyer and there is also no Dr. Peter Klein in the USA as a lawyer, which is why it is clear that Rainer von Holst alias Jan Faber, who also calls himself Dr. Peter Klein, is an internationally wanted fraudster, impostor and internet blackmailer, who has been acting as a blackmailer on the internet for many years with lies and slander of “gerlachreport” https://www.gerlachreport.com.

1)
https://www.notarypublicstamps.com/find-a-notary

2)
https://www.nationalnotary.org

3)
https://lawyers.findlaw.com

4)
https://www.hg.org/usacities.asp

Moreover, in the United States of America, a notary is a person appointed by the government of a state, for example by the governor and the lieutenant governor, but what US governor would allow himself to be photographed with a Rainer von Holst or even appoint an internationally wanted fraudster like Rainer von Holst as US notary?

The fact that Rainer von Holst demands from a German news agency, without any sense of injustice, that it refrain from disseminating reports about him, here in obviously boundless self-conceit, whereby he sounds full of pomposity that the renowned German newspaper “Kyffhäuser Nachrichten” had lost a lawsuit and would thus have to delete publications about him, is another brazen Rainer von Holst lie.
The “Kyffhäuser Nachrichten” is above reproach and is published in association with other media, such as: nnz-online.de, eichsfelder-nachrichten.de, msh-online.de, uhz-online.de, nordthueringen.de, nnz-tv.de, among others. The untrue statements made by Rainer von Holst to a news agency can once again be debunked within seconds, as the web link proves.
Source: https://www.kyffhaeuser-nachrichten.de/news/news_lang_druck.php?ArtNr=230553

As in many of his activities, Rainer von Holst is obviously relying on people being impressed by his baseless e-mail gibberish in the letters he writes. These times, however, are over, everything that comes from this person is currently being checked, the agencies and the media are informed about the actions of the internationally wanted fraudster, con man and internet blackmailer, Rainer von Holst. Where von Holst insists on data protection, he will be happy to enforce it when Rainer von Holst is arrested in the USA, extradited and stands trial.
The US embassies have been informed about the current press articles on Rainer von Holst and the non-existent Osint Group and, after receiving feedback, have commissioned investigations by the FBI (Federal Bureau of Investigation) in the USA.

It thus remains to be seen when Rainer von Holst, who has gone into hiding, will be arrested and stand trial together with his criminal network, with Article 6(2) of the ECHR applying.

META KEYS:
V999, Rainer von Holst, Jan Faber, Harald Seiz, Dr. Peter Klein, Peter Klein, Karatbars, Federal Bureau of Investigation, FBI, Osint Group, Jakob B., Chris Saunders, Whitepaper V999, BUV, UNV

Legally responsible for this press release:
GSB Gold Standard Banking Corporation AG
Grosse Bleichen 35
D-20354 Hamburg
Register of the Hamburg Local Court, No: HRB 161409
Federal Republic of Germany

Press Department:
Mrs. Berger
Phone: +49 40 376 69 19 – 0
Fax: +49 40 376 69 89 – 3
Mail: Media@GSB.gold

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1d692296-8b08-4f61-97e3-27c0f70600d3

LeddarTech launches Leddar™ Sight, a robust, cost-effective 2D solid-state LiDAR sensor.

Unmatched Robustness for the Most Demanding Environments

Based on the Leddar M16 2D flash LiDAR module family’s field-proven reliability, the Leddar Sight leverages a 100% solid-state design for ultimate robustness. Tested for shock and vibration to meet the most demanding commercial and industrial applications requirements, Leddar Sight features a weatherproof casing (IP67/IP69 rated) that resists dust ingress, immersion, and pressurized water streams.

Accelerated Path to Commercial Deployment

The Leddar Sight 2D flash LiDAR provides precise detection and measurement capabilities for indoor applications such as industrial automation and various outdoor applications such as autonomous navigation, obstacle detection, collision avoidance, precision maneuvering, speed enforcement, and automated tolling. Thanks to its robust enclosure, M12 connector, and various FoV options, the sensor can be rapidly integrated into prototypes and used to collect field data for software development and is available in volume today to customers, system integrators, and resellers for commercial deployments.

The Leddar Sight is an ideal LiDAR solution for shuttles, robotaxis, ADVs, commercial trucks, buses, industrial vehicles, mobile robotics, and intelligent transportation systems.

Leddar Sight 2D Solid-State LiDAR Key Features

• 100% solid-state
• 400,000 hours MTBF, up to 26X longer than mechanical LiDARs
• Meets stringent shock and vibration standards
• IP67/IP69 rated, impact-resistant enclosure
• High EMC standards
• Wide operating temperature range

“This new offering in our 2D flash LiDAR portfolio addresses a critical need expressed by our customers for a reliable, affordable LiDAR sensor that can operate in challenging conditions where shocks, vibrations, water and dust ingress, and wide operating temperature ranges are key concerns,” said Daniel Aitken, Vice President of Global Marketing, Communications, and Product Management from LeddarTech. “Unlike mechanical LiDARs, Leddar Sight uses a proven solid-state flash design which delivers much longer inherent MTBF, and its robust casing makes it field-ready for 24/7 operation in the harshest commercial and industrial settings.”

About LeddarTech

LeddarTech is a leader in environmental sensing platforms for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing and perception challenges across the entire value chain of the automotive and mobility market segments. With its LeddarVision™ sensor-fusion and perception platform and its cost-effective, scalable, and versatile LiDAR development solution for automotive-grade solid-state LiDARs based on the LeddarEngine™, LeddarTech enables Tier 1-2 automotive system integrators to develop full-stack sensing solutions for autonomy level 1 to 5. These solutions are actively deployed in autonomous shuttles, trucks, buses, delivery vehicles, smart cities/factories, and robotaxi applications. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 95 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook, and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications, and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names, and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/645d13a2-1348-4cb0-bdea-21f4668ce468

JobDiva Integrates with Jobs on Facebook

Jobs on Facebook makes it simple for employers and recruiters to post jobs, manage applications and communicate with candidates more easily. By synchronizing job openings, JobDiva’s integration with Jobs on Facebook empowers businesses to reach candidates where they are spending significant amounts of time.

“At JobDiva, we are focused on reducing unemployment during these uncertain times, as well as matching the workforce with their desired opportunities by maximizing our clients’ capabilities—and doing so quickly, in the interest of the public at large,” said Gus Samra, JobDiva’s Chief Revenue Officer. “JobDiva’s integration with Jobs on Facebook is a signal example of our commitment to talent and client success, and we’re ecstatic to offer this integration.”

About JobDiva: JobDiva, the leading global ATS, is delivered to clients via the cloud. JobDiva stands as the top-tier ATS, defining the path of innovation in staffing technology.

Contact:
Bella Chen
Head of Marketing, JobDiva
Bella.chen@jobdiva.com
+1 212-384-6566

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/65890c74-c25d-4a3c-a1a1-b11802201711

 

Enhanced Infusion System (EIS)

• Analytica signs agreement with Marwa for distribution, marketing and sales of the Enhanced Infusion System (EIS) in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and United Arab Emirates.
• Patented IV add-in infusion system reduces infection and embolism risk and saves medical staff time for an overall lower total cost than existing equipment and practices.

BRISBANE, Australia, April 27, 2021 (GLOBE NEWSWIRE) — Analytica Limited (ASX:ALT), the Australian developer of the Enhanced Infusion System (EIS) and PeriCoach^® pelvic floor exercise system for the treatment of stress urinary incontinence, has entered into an agreement with Marwa’s Office for Export & Import Medical Supplies (Marwa) to distribute, market and sell the EIS to hospital systems in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and United Arab Emirates.

The EIS technology was developed by Analytica under the project names AutoStart and AutoFlush and has been sold in Australia with the trade name FirstFlow™^,¹ under limited license. EIS combines the AutoStart and AutoFlush patented technologies into a simple and inexpensive solution.

The patented float system automatically restarts IV fluid flow following medication delivery, thereby saving healthcare workers’ time, reducing hospital costs and preventing the adverse events associated with air embolism and failure of Peripheral Intravenous Catheters (PIVC). The EIS reacts immediately, silently and without intervention or programming. It can be retrofitted to any existing infusion system design and can work in harmony with and improve the capability of any infusion pump or ‘bag’ infusion system, regardless of sophistication.

Use of the EIS uniquely allows a completely closed infusion system, with integrity achieved by reducing the interactions believed to cause mechanical and vascular complications as well as good flushing and/or patency practice.

The EIS has an Australian TGA ARTG registration and USFDA 510(k) clearance. It is fully compliant with ISO 8536 infusion system and other relevant standards.

The EIS can markedly reduce legal risks by addressing multiple factors that can impact patients, clinicians and hospitals, including:

• Air Embolism – The EIS has a large and heavy float valve ensuring complete, long-term seal. The unique float maintains a seal even at extreme angles (up to 60 degrees from horizontal), making the device usable in ambulances, retrieval and military situations and reducing the risk of mortality and morbidity associated with air embolism.
• Open/Closed Delivery System – The needle-free access port is the only entry point, with only one syringe necessary per medication event. Using the existing 1L IV bag means replacement is less frequent than 100mL pre-mix bags, saving time and money and reducing the risk of contamination and infection.
• Syringe Flush – This feature eliminates the requirement to introduce an additional flushing syringe and bolus. Flushing prevents interactions between incompatible fluids/medications, thus reducing the risk of cross contamination and strengthening infection control.
• Catheter Flush – This feature reduces the risk of PIVC failure with the automatic, immediate restart of IV flow after medication delivery, which allows continuous maintenance flow to the flush line and catheter. This also maintains catheter patency by preventing internal luminal occlusion.
• Medication Dilution – The Interrupted Therapy feature allows the introduction of medication through EIS to accurately measure IV fluid mix rather than 3-way valve and bags.
• Infection Risk – Observational studies demonstrate high incidence of non-conformance to hand washing and flushing protocol. EIS limits access and infection opportunity.
• Flushing pressure – Bolus flush of catheter may vary based on syringe size and pressure. The proprietary float design ensures constant flushing pressure, reducing the risk of PIVC failure.

Given the health and legal risk-reduction features of the EIS, the home-based hospital care market represents a growth opportunity globally. The EIS is compact, rugged and does not require a pump or energy source, which makes it suitable for retrieval, military and third world needs without compromising risk.

To view a video about the operation and features of the EIS, please click here.

Marwa’s Principal has extensive experience with the Egyptian health system, as a consultant and undersecretary of health for the Egyptian Health Insurance Organization Clinics (HIO) as well as leadership positions in the Egyptian Ministry of Health.

“Marwa has presented a compelling opportunity with experienced professionals to take Analytica’s Enhanced Infusion System (EIS) into a large and growing market in the Middle East,” said Dr. Michael Monsour, Chairman of Analytica Ltd. “We look forward to working with Marwa to expand the usage of our unique EIS technology.”

For more information about Analytica and the Enhanced Infusion System, visit www.AnalyticaMedical.com

For investor or business inquiries, please contact: investorrelations@analyticamedical.com

For media inquiries, please contact: Annie Starr, astarr@6degreespr.com

About Analytica Limited

Analytica is a product development and commercialisation company based in Brisbane, Australia that is focussed on Class I and II medical device products.

Analytica is the developer of the Enhanced Infusion System (EIS), a combination of patented technologies developed under the project names AutoStart and AutoFlush. The EIS is a simple and inexpensive IV add-in technology to decrease nursing monitoring costs, reduce embolism risk, improve infection control, and automatically restart flow after medication delivery during intravenous fluid infusion.

Analytica is also the manufacturer of the PeriCoach^® System, an e-health treatment system for women who suffer stress urinary incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles because of pregnancy, childbirth and menopause.

____________________

¹ Trademark of ICU Medical Australia.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d7af8a18-4b05-4cae-a8bb-71d578ab84fc